Literature DB >> 3114790

Anxiolytic-like action of the 3-PPP enantiomers in the Vogel conflict paradigm.

S Hjorth, A Carlsson, J A Engel.   

Abstract

The effect of the (+)- and (-)-enantiomers of 3-PPP [conventional and atypical dopamine (DA)-receptor active agent, respectively] were investigated in a commonly used animal model of anxiety: the Vogel licking-conflict test. Low doses (less than or equal to 0.5 mg/kg SC) of both 3-PPP enantiomers resulted in anti-conflict (= anxiolytic-like) actions in this test. (-)-3-PPP proved to be almost as potent as apomorphine in releasing the punished responding (minimum effective doses; (-)-3-PPP: 0.016, and apomorphine: 0.006 mg/kg SC), whereas (+)-3-PPP was about 10 times less effective than apomorphine. In the higher dose range (greater than or equal to 1.0 mg/kg), both 3-PPP enantiomers instead induced an apparent "pro"-conflict effect; i.e. decreased responding to a level significantly below baseline, thus resulting in a biphasic dose-response curve. Simple alterations in the animals' motivation to drink, in shock threshold or in motor capabilities did not seem to be major explanatory factors either for the anti- or for the "pro"-conflict effects. With regard to the latter, the possibility is discussed of an interaction between the experimental test situation and non conflict-related effects of the drugs, thus interfering with the punished drinking. The findings are interpreted within the concept that low doses of the 3-PPP enantiomers, in particular (-)-3-PPP, may attenuate anxiety-elicited increases in the neurotransmission in certain meso-cortical/limbic DA pathways, i.e. consistent with the previously shown preferentially "limbic" net antidopaminergic profile of action of (-)-3-PPP.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3114790     DOI: 10.1007/bf00210846

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  26 in total

1.  Mesocortical dopamine neurons. Lack of autoreceptors modulating dopamine synthesis.

Authors:  M J Bannon; R L Michaud; R H Roth
Journal:  Mol Pharmacol       Date:  1981-03       Impact factor: 4.436

Review 2.  Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of the evidence.

Authors:  D Clark; S Hjorth; A Carlsson
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

3.  Demonstration of autoreceptors on dopamine neurons in different brain regions of rats treated with gammabutyrolactone.

Authors:  N E Andén; M Grabowska-Andén; B Liljenberg
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

Review 4.  Dopamine receptor agonists: mechanisms underlying autoreceptor selectivity. II. Theoretical considerations.

Authors:  D Clark; S Hjorth; A Carlsson
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

5.  Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons.

Authors:  L A Chiodo; M J Bannon; A A Grace; R H Roth; B S Bunney
Journal:  Neuroscience       Date:  1984-05       Impact factor: 3.590

6.  Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).

Authors:  J A Engel; S Hjorth; K Svensson; A Carlsson; S Liljequist
Journal:  Eur J Pharmacol       Date:  1984-10-15       Impact factor: 4.432

7.  Dopamine receptor agonists: intrinsic activity vs. state of receptor.

Authors:  A Carlsson
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

8.  (+)- and (-)-3-PPP exhibit different intrinsic activity at striatal dopamine autoreceptors controlling dopamine synthesis.

Authors:  D Clark; S Hjorth; A Carlsson
Journal:  Eur J Pharmacol       Date:  1984-10-30       Impact factor: 4.432

9.  Synthesis rate of dopamine: difference between corpus striatum and limbic system as a possible explanation of variations in reactions to drugs.

Authors:  N E Andén; M Grabowska-Andén; S Lindgren; U Thornström
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-07       Impact factor: 3.000

10.  Footshock and conditioned stress increase 3,4-dihydroxyphenylacetic acid (DOPAC) in the ventral tegmental area but not substantia nigra.

Authors:  A Y Deutch; S Y Tam; R H Roth
Journal:  Brain Res       Date:  1985-04-29       Impact factor: 3.252

View more
  4 in total

1.  LY 171555-induced hyperdefensiveness in the mouse does not implicate benzodiazepine receptors.

Authors:  C Belzung; S Cabib; L Fabiani; P Tolentino; S Puglisi-Allegra
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  The role of dopaminergic mechanisms on the brain in various models of anxious states.

Authors:  A N Talalaenko; I A Abramets; A A Shekhovtsov; A V Chernikov; S L Shevchenko
Journal:  Neurosci Behav Physiol       Date:  1994 May-Jun

3.  Suppression of neuroleptic-induced persistent abnormal movements in Cebus apella monkeys by enantiomers of 3-PPP.

Authors:  B Kovacic; P Le Witt; D Clark
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

4.  Limited stimulus generalization between delta 9-THC and diazepam in pigeons and gerbils.

Authors:  T U Järbe; A J Hiltunen
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.